scorecardresearch
Follow Us:
Tuesday, June 22, 2021

New research: Drug shown to block multiple coronavirus variants in mice

The findings, published in Science Immunology, suggest that diABZI could also treat other respiratory coronaviruses.

By: Express News Service | New Delhi |
Updated: May 29, 2021 7:54:21 am
The researchers found that diABZI potently inhibits SARS-CoV-2 infection of diverse strains, including B.1.351. (Unsplash/Representational)

The drug diABZI — which activates the body’s innate immune response — was highly effective in preventing severe COVID-19 in mice that were infected with SARS-CoV-2, according to scientists in the Perelman School of Medicine at the University of Pennsylvania.

The findings, published in Science Immunology, suggest that diABZI could also treat other respiratory coronaviruses.

To identify antiviral agonists that would block SARS-CoV-2 infection, the researchers performed high throughput screening of 75 drugs that target sensing pathways in lung cells.

The team also tested a newly-developed small molecule STING agonist called diABZI, which is not approved by the US Food and Drug Administration but is currently being tested in clinical trials to treat some cancers.

The researchers found that diABZI potently inhibits SARS-CoV-2 infection of diverse strains, including B.1.351.

Source: Penn Medicine News

📣 The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay updated with the latest headlines

For all the latest Explained News, download Indian Express App.

  • The Indian Express website has been rated GREEN for its credibility and trustworthiness by Newsguard, a global service that rates news sources for their journalistic standards.
0 Comment(s) *
* The moderation of comments is automated and not cleared manually by indianexpress.com.
Advertisement
Advertisement
Advertisement
Advertisement